Location History:
- Silver Spring, MD (US) (1993 - 1998)
- Bethesda, MD (US) (2002)
- Baltimore, MD (US) (2009 - 2018)
- Ellicott City, MD (US) (2010 - 2021)
Company Filing History:
5 out of 3,435 
4 out of 1,215 
4 out of 203 
Years Active: 1993-2021
Title: The Innovative Contributions of Richard B Rothman
Introduction: Richard B Rothman is a prominent inventor based in Baltimore, MD, known for his significant contributions to the field of neuropharmacology. With a remarkable portfolio of 12 patents, Rothman has dedicated his career to developing compounds that play a crucial role in treating various neurological disorders. His innovative work focuses on novel neurotransmitter releasers and transport modulators, which have the potential to change therapeutic approaches for many conditions.
Latest Patents: Among Richard B Rothman’s latest patents are two notable innovations:
1. **Vinylogous Phenethylamines as Neurotransmitter Releasers** - This patent discloses compounds that act as monoamine neurotransmitter releasers and/or uptake inhibitors. These compounds exhibit biogenic amine transporter activity while demonstrating minimal activity at 5-HT receptor subtypes. They hold promising applications for treating diseases related to monoamine neurotransmitters.
2. **Quinazolines as Biogenic Amine Transport Modulators** - This patent relates to amine derivatives of fused bicyclic heterocycles that inhibit the reuptake function of biogenic amine transporters, such as dopamine, serotonin, and norepinephrine transporters. The compounds developed provide a new means to treat depression, pain, and issues related to substance abuse.
Career Highlights: Richard B Rothman has made significant strides in the field of neuroscience and pharmacology. His patents reflect a deep understanding of biogenic amines and their roles in various disorders, emphasizing his innovative thinking and commitment to enhancing patient care through scientific advancement.
Collaborations: Throughout his career, Rothman has collaborated with esteemed colleagues, including Subramaniam Ananthan and Bruce Edward Blough. These partnerships have further enriched his research and contributed to the successful development of his patent portfolio. Additionally, he has worked with reputable organizations such as the United States Department of Health and Southern Research Institute.
Conclusion: Richard B Rothman's work stands at the forefront of medicinal chemistry and neuropharmacology. His contributions through innovative patents not only highlight his role as a leading inventor but also underscore the potential impact of his research on improving therapeutic outcomes for individuals suffering from neurological disorders. Through collaboration and a commitment to advancing medical science, Rothman continues to inspire future innovations in the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.